Business Context and Reporting Period
This Form 6-K filing by BiondVax Pharmaceuticals Ltd. (not Scinai Immunotherapeutics Ltd.) covers the month of December 2019. The registrant is a foreign private issuer based in Jerusalem, Israel, operating in the pharmaceutical sector.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural announcement regarding a corporate meeting and does not contain financial statements.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this document.
Guidance, Outlook, and Management Commentary
The Company announced it will hold an Annual General Meeting of Shareholders on February 11, 2020, at 4:00 p.m. Israel time. The meeting will be held at the offices of Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. in Tel Aviv, Israel. A Notice of the meeting is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the correct registrant name is BiondVax Pharmaceuticals Ltd., not Scinai Immunotherapeutics Ltd.
- Confirm the date, time, and location of the Annual General Meeting scheduled for February 11, 2020.
- Review the attached Notice of Annual General Meeting (Exhibit 99.1) for specific agenda items and voting procedures.
- Note that this filing contains no financial data; refer to the most recent Form 20-F for financial metrics.